Remsima (a Tumor Necrosis Factor (TNF) -α Inhibitor) induced hemolysis in a patient with Crohn's disease - Case report

INTRODUCTION: Crohn's disease (CD) is an idiopathic inflammatory disorder of unknown etiology with genetic, immunologic, and environmental influences. Infliximab is a treatment modality for fistulated Crohn's disease. Infliximab induced hemolysis is rare and very few cases reported before...

Descripción completa

Detalles Bibliográficos
Autores principales: AL-Ansari, Rehab Y., Khuraim, Arwa AL., Abdalla, Leena, Hamid, Hind, Zakary, N.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403549/
https://www.ncbi.nlm.nih.gov/pubmed/34484733
http://dx.doi.org/10.1016/j.amsu.2021.102768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403549/
https://www.ncbi.nlm.nih.gov/pubmed/34484733
http://dx.doi.org/10.1016/j.amsu.2021.102768

Ejemplares similares